Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 321 publications
Evaluating deucrictibant for the treatment of hereditary angioedema.
Journal: Expert opinion on pharmacotherapy
Published: August 24, 2026
Lonvoguran ziclumeran: a CRISPR-CAS9-based gene therapy for the treatment of hereditary angioedema.
Journal: Expert opinion on investigational drugs
Published: July 27, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary Angioedema.
Journal: The New England journal of medicine
Published: June 15, 2026
Utility of basophil activation tests in the diagnosis of cross-intolerance to nonsteroidal anti-inflammatory drug reactions.
Journal: Allergy and asthma proceedings
Published: April 29, 2026
Prevalence and Incidence of Hereditary Angioedema: A Systematic Literature Review.
Journal: International archives of allergy and immunology
Published: April 24, 2026
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis.
Journal: Advances in therapy
Published: February 23, 2026
The definition of response and inadequate response to topical corticosteroid treatment in atopic dermatitis and related skin inflammatory diseases: A GA2LEN ADCARE statement paper.
Journal: The World Allergy Organization journal
Published: January 28, 2026
Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1.
Journal: Journal of asthma and allergy
Published: January 21, 2026
The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities.
Journal: The World Allergy Organization journal
Published: January 14, 2026
Diagnosis and management of pediatric and adolescent hereditary angioedema: A clinical yardstick.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: January 14, 2026
Donidalorsen for the Treatment of Hereditary Angioedema: A Review of Clinical Studies.
Journal: Drug design, development and therapy
Published: January 07, 2026
Lanadelumab in Hereditary Angioedema: Extending Dose Intervals from Every 2 Weeks to Every 4 Weeks.
Journal: International archives of allergy and immunology
Published: December 21, 2025
Last Updated: 09/26/2026